Loss of PIM2 enhances the anti-proliferative effect of the pan-PIM kinase inhibitor AZD1208 in non-Hodgkin lymphomas

Kreuz, S, Holmes, KB, Tooze, RM et al. (1 more author) (2015) Loss of PIM2 enhances the anti-proliferative effect of the pan-PIM kinase inhibitor AZD1208 in non-Hodgkin lymphomas. Molecular Cancer, 14. 205. ISSN 1476-4598

Abstract

Metadata

Authors/Creators:
  • Kreuz, S
  • Holmes, KB
  • Tooze, RM
  • Lefevre, PF
Copyright, Publisher and Additional Information: © 2015 Kreuz et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Keywords: PIM kinase; c-MYC; Lymphoma; BL; DLBCL
Dates:
  • Published: 8 December 2015
  • Accepted: 2 December 2015
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Experimental Haematology (Leeds)
Funding Information:
FunderGrant number
Yorkshire Cancer ResearchL002 PHD
Depositing User: Symplectic Publications
Date Deposited: 25 Jan 2016 12:44
Last Modified: 12 Feb 2019 13:07
Published Version: http://dx.doi.org/10.1186/s12943-015-0477-z
Status: Published
Publisher: BioMed Central
Identification Number: https://doi.org/10.1186/s12943-015-0477-z
Related URLs:

Share / Export

Statistics